These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 10627454

  • 1. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M, Takaluoma K, Aittomäki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O.
    Blood; 2000 Jan 15; 95(2):494-502. PubMed ID: 10627454
    [Abstract] [Full Text] [Related]

  • 2. p38 Mitogen-activated protein kinase regulates interleukin-4-induced gene expression by stimulating STAT6-mediated transcription.
    Pesu M, Aittomäki S, Takaluoma K, Lagerstedt A, Silvennoinen O.
    J Biol Chem; 2002 Oct 11; 277(41):38254-61. PubMed ID: 12161424
    [Abstract] [Full Text] [Related]

  • 3. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
    Wang HY, Zamorano J, Keegan AD.
    J Biol Chem; 1998 Apr 17; 273(16):9898-905. PubMed ID: 9545332
    [Abstract] [Full Text] [Related]

  • 4. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F, Gao G, Wang LM, Landstrom TR, Degerman E, Pierce JH, Manganiello VC.
    J Immunol; 1999 Apr 15; 162(8):4864-75. PubMed ID: 10202031
    [Abstract] [Full Text] [Related]

  • 5. IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes.
    Wick KR, Berton MT.
    Mol Immunol; 2000 Aug 15; 37(11):641-52. PubMed ID: 11164892
    [Abstract] [Full Text] [Related]

  • 6. Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.
    Schnyder B, Lahm H, Pittet M, Schnyder-Candrian S.
    J Recept Signal Transduct Res; 2002 Aug 15; 22(1-4):213-28. PubMed ID: 12503617
    [Abstract] [Full Text] [Related]

  • 7. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules.
    Chen XH, Patel BK, Wang LM, Frankel M, Ellmore N, Flavell RA, LaRochelle WJ, Pierce JH.
    J Biol Chem; 1997 Mar 07; 272(10):6556-60. PubMed ID: 9045682
    [Abstract] [Full Text] [Related]

  • 8. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
    Murata T, Obiri NI, Puri RK.
    Int J Cancer; 1997 Jan 17; 70(2):230-40. PubMed ID: 9009165
    [Abstract] [Full Text] [Related]

  • 9. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
    Murata T, Puri RK.
    Cell Immunol; 1997 Jan 10; 175(1):33-40. PubMed ID: 9015186
    [Abstract] [Full Text] [Related]

  • 10. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
    Murata T, Noguchi PD, Puri RK.
    J Immunol; 1996 Apr 15; 156(8):2972-8. PubMed ID: 8609418
    [Abstract] [Full Text] [Related]

  • 11. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
    Gingras S, Côté S, Simard J.
    Mol Endocrinol; 2000 Feb 15; 14(2):229-40. PubMed ID: 10674396
    [Abstract] [Full Text] [Related]

  • 12. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
    Friedrich K, Kammer W, Erhardt I, Brändlein S, Sebald W, Moriggl R.
    Int Immunol; 1999 Aug 15; 11(8):1283-94. PubMed ID: 10421786
    [Abstract] [Full Text] [Related]

  • 13. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.
    Moriggl R, Erhardt I, Kammer W, Berchtold S, Schnarr B, Lischke A, Groner B, Friedrich K.
    Eur J Biochem; 1998 Jan 15; 251(1-2):25-35. PubMed ID: 9492265
    [Abstract] [Full Text] [Related]

  • 14. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
    Oakes SA, Candotti F, Johnston JA, Chen YQ, Ryan JJ, Taylor N, Liu X, Hennighausen L, Notarangelo LD, Paul WE, Blaese RM, O'Shea JJ.
    Immunity; 1996 Dec 15; 5(6):605-15. PubMed ID: 8986719
    [Abstract] [Full Text] [Related]

  • 15. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
    Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, Kuwano M, Nakajima K, Hamasaki N, Izuhara K.
    Int Immunol; 2000 Nov 15; 12(11):1499-509. PubMed ID: 11058569
    [Abstract] [Full Text] [Related]

  • 16. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
    Carlesso N, Frank DA, Griffin JD.
    J Exp Med; 1996 Mar 01; 183(3):811-20. PubMed ID: 8642285
    [Abstract] [Full Text] [Related]

  • 17. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
    Lischke A, Moriggl R, Brändlein S, Berchtold S, Kammer W, Sebald W, Groner B, Liu X, Hennighausen L, Friedrich K.
    J Biol Chem; 1998 Nov 20; 273(47):31222-9. PubMed ID: 9813029
    [Abstract] [Full Text] [Related]

  • 18. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN, Kohanski RA, Wang LH, Sadowski HB.
    Mol Endocrinol; 2002 Dec 20; 16(12):2764-79. PubMed ID: 12456798
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction.
    Lütticken C, Coffer P, Yuan J, Schwartz C, Caldenhoven E, Schindler C, Kruijer W, Heinrich PC, Horn F.
    FEBS Lett; 1995 Feb 27; 360(2):137-43. PubMed ID: 7533107
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
    Beadling C, Ng J, Babbage JW, Cantrell DA.
    EMBO J; 1996 Apr 15; 15(8):1902-13. PubMed ID: 8617237
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.